124 related articles for article (PubMed ID: 21878740)
21. Narcotics and diabetes. II. Streptozotocin-induced diabetes selectively alters the potency of certain narcotic analgesics. Mechanism of diabetes: morphine interaction.
Simon GS; Borzelleca J; Dewey WL
J Pharmacol Exp Ther; 1981 Aug; 218(2):324-9. PubMed ID: 6114167
[TBL] [Abstract][Full Text] [Related]
22. The role of nitric oxide in diabetes-induced changes of morphine tolerance in rats.
Joharchi K; Jorjani M
Eur J Pharmacol; 2007 Sep; 570(1-3):66-71. PubMed ID: 17599829
[TBL] [Abstract][Full Text] [Related]
23. [Compound matrine injection reduces morphine tolerance of the mice with lung cancer by inhibiting expression of multidrug resistance gene 1 and P-glycoprotein].
Sun YZ; You RL; Wang L; Ren JS; Wang DY; Su SJ; Xu RF
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):216-221. PubMed ID: 32252200
[No Abstract] [Full Text] [Related]
24. Inhibition of NF-κB activity by aminoguanidine alleviates neuroinflammation induced by hyperglycemia.
Song Y; Zhang F; Ying C; Kumar KA; Zhou X
Metab Brain Dis; 2017 Oct; 32(5):1627-1637. PubMed ID: 28634786
[TBL] [Abstract][Full Text] [Related]
25. Functional alterations of intestinal P-glycoprotein under diabetic conditions.
Kobori T; Harada S; Nakamoto K; Tokuyama S
Biol Pharm Bull; 2013; 36(9):1381-90. PubMed ID: 23995645
[TBL] [Abstract][Full Text] [Related]
26. Modulatory role of green tea extract on antinociceptive effect of morphine in diabetic mice.
Singal A; Anjaneyulu M; Chopra K
J Med Food; 2005; 8(3):386-91. PubMed ID: 16176152
[TBL] [Abstract][Full Text] [Related]
27. Baicalin reduces ciclosporin bioavailability by inducing intestinal p-glycoprotein in rats.
Tian X; Chang Y; Wei J; Liu R; Wang L; Zhang J; Zhang X
J Pharm Pharmacol; 2019 May; 71(5):788-796. PubMed ID: 30663770
[TBL] [Abstract][Full Text] [Related]
28. Chronic morphine exposure potentiates p-glycoprotein trafficking from nuclear reservoirs in cortical rat brain microvessels.
Schaefer CP; Arkwright NB; Jacobs LM; Jarvis CK; Hunn KC; Largent-Milnes TM; Tome ME; Davis TP
PLoS One; 2018; 13(2):e0192340. PubMed ID: 29414996
[TBL] [Abstract][Full Text] [Related]
29. Thalidomide attenuates the development and expression of antinociceptive tolerance to μ-opioid agonist morphine through l-arginine-iNOS and nitric oxide pathway.
Khan MI; Ostadhadi S; Mumtaz F; Momeny M; Moghaddaskho F; Hassanipour M; Ejtemaei-Mehr S; Dehpour AR
Biomed Pharmacother; 2017 Jan; 85():493-502. PubMed ID: 27899254
[TBL] [Abstract][Full Text] [Related]
30. Gabapentin enhances the analgesic effect of morphine in healthy volunteers.
Eckhardt K; Ammon S; Hofmann U; Riebe A; Gugeler N; Mikus G
Anesth Analg; 2000 Jul; 91(1):185-91. PubMed ID: 10866910
[TBL] [Abstract][Full Text] [Related]
31. Vitamin K1 alleviates streptozotocin-induced type 1 diabetes by mitigating free radical stress, as well as inhibiting NF-κB activation and iNOS expression in rat pancreas.
Varsha MK; Thiagarajan R; Manikandan R; Dhanasekaran G
Nutrition; 2015 Jan; 31(1):214-22. PubMed ID: 25466668
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological characterization of standard analgesics on mechanical allodynia in streptozotocin-induced diabetic rats.
Yamamoto H; Shimoshige Y; Yamaji T; Murai N; Aoki T; Matsuoka N
Neuropharmacology; 2009 Sep; 57(4):403-8. PubMed ID: 19591853
[TBL] [Abstract][Full Text] [Related]
33. The pharmacokinetics of morphine and its glucuronide conjugate in a rat model of streptozotocin-induced diabetes and the expression of MRP2, MRP3 and UGT2B1 in the liver.
Hasegawa Y; Kishimoto S; Shibatani N; Nomura H; Ishii Y; Onishi M; Inotsume N; Takeuchi Y; Fukushima S
J Pharm Pharmacol; 2010 Mar; 62(3):310-4. PubMed ID: 20487213
[TBL] [Abstract][Full Text] [Related]
34. Olive leaf down-regulates the oxidative stress and immune dysregulation in streptozotocin-induced diabetic mice.
Park JH; Jung JH; Yang JY; Kim HS
Nutr Res; 2013 Nov; 33(11):942-51. PubMed ID: 24176234
[TBL] [Abstract][Full Text] [Related]
35. Antinociceptive effects of the 6-O-sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors.
Yadlapalli JSK; Ford BM; Ketkar A; Wan A; Penthala NR; Eoff RL; Prather PL; Dobretsov M; Crooks PA
Pharmacol Res; 2016 Nov; 113(Pt A):335-347. PubMed ID: 27637375
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic assessment of absorptive interaction of oral etoposide and morphine in rats.
Miyazaki M; Nishimura C; Minamida M; Iwanaga K; Kakemi M
Biol Pharm Bull; 2014; 37(3):371-7. PubMed ID: 24351551
[TBL] [Abstract][Full Text] [Related]
37. Decreased basal endogenous opioid levels in diabetic rodents: effects on morphine and delta-9-tetrahydrocannabinoid-induced antinociception.
Williams J; Haller VL; Stevens DL; Welch SP
Eur J Pharmacol; 2008 Apr; 584(1):78-86. PubMed ID: 18313663
[TBL] [Abstract][Full Text] [Related]
38. Opiate-induced analgesia is increased and prolonged in mice lacking P-glycoprotein.
Thompson SJ; Koszdin K; Bernards CM
Anesthesiology; 2000 May; 92(5):1392-9. PubMed ID: 10781286
[TBL] [Abstract][Full Text] [Related]
39. Diosmetin Attenuates Akt Signaling Pathway by Modulating Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-κB)/Inducible Nitric Oxide Synthase (iNOS) in Streptozotocin (STZ)-Induced Diabetic Nephropathy Mice.
Jiang Y; Liu J; Zhou Z; Liu K; Liu C
Med Sci Monit; 2018 Oct; 24():7007-7014. PubMed ID: 30278036
[TBL] [Abstract][Full Text] [Related]
40. Involvement of moesin in the development of morphine analgesic tolerance through P-glycoprotein at the blood-brain barrier.
Kobori T; Fujiwara S; Miyagi K; Harada S; Nakamoto K; Nakagawa T; Takahashi H; Narita M; Tokuyama S
Drug Metab Pharmacokinet; 2014; 29(6):482-9. PubMed ID: 25048710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
